Clinical Trial Detail

NCT ID NCT02210104
Title Adoptive Therapy Using Antigen-Specific CD4 T-Cells
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements no
Sponsors M.D. Anderson Cancer Center
Indications

synovial sarcoma

liposarcoma

melanoma

Therapies

Ipilimumab

Cyclophosphamide

Age Groups: adult

No variant requirements are available.